دورية أكاديمية

Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

التفاصيل البيبلوغرافية
العنوان: Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
المؤلفون: Rücker, Frank G. *, Agrawal, Mridul *, Corbacioglu, Andrea *, Weber, Daniela, Kapp-Schwoerer, Silke, Gaidzik, Verena I., Jahn, Nikolaus, Schroeder, Thomas, Wattad, Mohammed, Lübbert, Michael, Koller, Elisabeth, Kindler, Thomas, Götze, Katharina, Ringhoffer, Mark, Westermann, Jörg, Fiedler, Walter, Horst, Heinz A., Greil, Richard, Schroers, Roland, Mayer, Karin, Heinicke, Thomas, Krauter, Jürgen, Schlenk, Richard F., Thol, Felicitas, Heuser, Michael, Ganser, Arnold, Bullinger, Lars, Paschka, Peter, Döhner, Hartmut, Döhner, Konstanze
المصدر: In Blood 7 November 2019 134(19):1608-1618
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00064971
DOI:10.1182/blood.2019001425